Aspen Pharmacare Holdings Overview

Aspen Pharmacare Holdings Cost of Revenue

Cost of Revenue analysis for APNHY.

Quarterly Cost of Revenue

$9.17B

↓ 20.3% YoY

As of Dec 31, 2025

Annual Cost of Revenue (TTM)

$40.13B

↑ 64.57% YoY

Trailing 12 months ending Dec 31, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin